Flow Forward is developing a novel approach to rapidly establish high-quality vascular access sites for hemodialysis. The Arteriovenous Fistula Eligibility (AFE) System™ is a small, temporary, external blood pump designed to stimulate flow-mediated dilation to make more patients eligible for an arteriovenous fistula (AVF), and increase success rates after surgery. Establishment of a reliable AVF reduces morbidity and mortality in hemodialysis patients, as well as the overall cost of care. For additional information, please visit www.flowforwardmedical.com.
Company’s Keywords:
medical devices & vascular access for hemodialysis
5
medical devices
5000000
Cloudflare DNS, CloudFlare Hosting, Google AdSense, Mobile Friendly, Google Plus, Bootstrap Framework, Google Font API, Apache, Google Maps, StatCounter, Clicky, WordPress.org, Nginx
2014